Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 4
2005 2
2006 3
2007 1
2008 2
2009 6
2010 6
2011 2
2012 2
2013 7
2014 5
2015 4
2016 6
2017 9
2018 7
2019 5
2020 8
2021 9
2022 8
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
High-dose vitamin C enhances cancer immunotherapy.
Magrì A, Germano G, Lorenzato A, Lamba S, Chilà R, Montone M, Amodio V, Ceruti T, Sassi F, Arena S, Abrignani S, D'Incalci M, Zucchetti M, Di Nicolantonio F, Bardelli A. Magrì A, et al. Among authors: zucchetti m. Sci Transl Med. 2020 Feb 26;12(532):eaay8707. doi: 10.1126/scitranslmed.aay8707. Sci Transl Med. 2020. PMID: 32102933 Free article.
Pseudo-resistance to anticancer drugs.
Davoli E, Zucchetti M, Giavazzi R, Garattini S, Frapolli R. Davoli E, et al. Among authors: zucchetti m. Ther Adv Med Oncol. 2022 Nov 14;14:17588359221136776. doi: 10.1177/17588359221136776. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36407785 Free PMC article. No abstract available.
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol.
Rizzari C, Möricke A, Valsecchi MG, Conter V, Zimmermann M, Silvestri D, Attarbaschi A, Niggli F, Barbaric D, Stary J, Elitzur S, Cario G, Vinti L, Boos J, Zucchetti M, Lanvers-Kaminsky C, von Stackelberg A, Biondi A, Schrappe M. Rizzari C, et al. Among authors: zucchetti m. Hemasphere. 2023 Jun 1;7(6):e893. doi: 10.1097/HS9.0000000000000893. eCollection 2023 Jun. Hemasphere. 2023. PMID: 37275740 Free PMC article.
Bioreducible Hydrophobin-Stabilized Supraparticles for Selective Intracellular Release.
Maiolo D, Pigliacelli C, Sánchez Moreno P, Violatto MB, Talamini L, Tirotta I, Piccirillo R, Zucchetti M, Morosi L, Frapolli R, Candiani G, Bigini P, Metrangolo P, Baldelli Bombelli F. Maiolo D, et al. Among authors: zucchetti m. ACS Nano. 2017 Sep 26;11(9):9413-9423. doi: 10.1021/acsnano.7b04979. Epub 2017 Aug 17. ACS Nano. 2017. PMID: 28806871 Free PMC article.
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.
Conter V, Valsecchi MG, Cario G, Zimmermann M, Attarbaschi A, Stary J, Niggli F, Dalla Pozza L, Elitzur S, Silvestri D, Locatelli F, Möricke A, Engstler G, Smisek P, Bodmer N, Barbaric D, Izraeli S, Rizzari C, Boos J, Buldini B, Zucchetti M, von Stackelberg A, Matteo C, Lehrnbecher T, Lanvers-Kaminsky C, Cazzaniga G, Gruhn B, Biondi A, Schrappe M. Conter V, et al. Among authors: zucchetti m. J Clin Oncol. 2024 Mar 10;42(8):915-926. doi: 10.1200/JCO.23.01388. Epub 2023 Dec 14. J Clin Oncol. 2024. PMID: 38096462
A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma.
Gallerani E, Zucchetti M, Brunelli D, Marangon E, Noberasco C, Hess D, Delmonte A, Martinelli G, Böhm S, Driessen C, De Braud F, Marsoni S, Cereda R, Sala F, D'Incalci M, Sessa C. Gallerani E, et al. Among authors: zucchetti m. Eur J Cancer. 2013 Jan;49(2):290-6. doi: 10.1016/j.ejca.2012.09.009. Epub 2012 Oct 8. Eur J Cancer. 2013. PMID: 23058787 Review.
91 results